MEDIUM-CHAIN TRIGLYCERIDES

Unresolved Excipient

Suggest One No specific molecular structure known for this excipient.
CAS
438544491
UNII
C9H2L21V7U
SYNONYMS
ZINC ID(s)
Availability
Present in 0 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Analogs cannot be located as there is no structure provided for this compound. Try a search by name.

Dosages

Route Formulation Per Unit Dose
Oral Capsule 140.56MG
Oral Capsule 124.95MG
Oral Capsule 158.94MG
Oral Capsule 159.98MG
Oral Capsule, Extended Release 3.08MG
Oral Capsule, Soft Gelatin 250MG
Oral Capsule, Soft Gelatin 99.77MG
Oral Capsule, Soft Gelatin 161.1MG
Oral Capsule, Soft Gelatin
Oral Capsule, Soft Gelatin Liquid-Filled 72.2MG
Oral Powder, For Oral Suspension 4.8%
Oral Powder, For Suspension 67.8%
Oral Solution 2.62%
Oral Solution 94.46%
Oral Tablet 0.34MG
Sublingual Spray 3.67%
Sublingual Spray, Metered 3.67%
Topical Aerosol, Spray
Topical Cream, Augmented 8%
Topical Cream, Augmented 1.37%
Topical Cream, Emulsion, Sustained Release 10%
Topical Cream, Emulsion, Sustained Release 1.37%
Topical Emulsion, Cream 10.8%
Topical Emulsion, Cream
Topical Gel 1%
Topical Lotion 7%
Topical Ointment 2.5%
Topical Ointment 18.8%W/W
Topical Ointment 20%
Topical Solution
Transdermal Film, Controlled Release

More Information

Usage Over Time

Comments